ksgA mutations confer resistance to kasugamycin in Neisseria gonorrhoeae

International Journal of Antimicrobial Agents

Volumn 33, Issue 4, 2009, Pages 321-327

  Duffin, Paul M ^a   Seifert, H Steven ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Antibiotic resistance; Gonorrhoea; Mutagenesis

Indexed keywords

KASUGAMYCIN; RIBOSOMAL PROTEIN S9; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; KASUGAMYCIN A GENE; MINIMUM INHIBITORY CONCENTRATION; MUTAGENESIS; MUTATIONAL ANALYSIS; NEISSERIA GONORRHOEAE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; MALE; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; NEISSERIA GONORRHOEAE; RIBOSOMAL PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 61449235258     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.08.030     Document Type: Article

References (48)

1. Ishiyama T., Hara I., Matsuoka M., Sato K., Shimada S., Izawa R., et al. Studies on the preventive effect of kasugamycin on rice blast. J Antibiot (Tokyo) 18 (1965) 115-119
2. Hamada M., Hashimoto T., Takahashi T., Yokoyama S., Miyake M., Takeuchi T., et al. Antimicrobial activity of kasugamycin. J Antibiot (Tokyo) 18 (1965) 104-106
3. Umezawa H., Hamada M., Suhara Y., Hashimoto T., and Ikekawa T. Kasugamycin, a new antibiotic. Antimicrob Agents Chemother 5 (1965) 753-757
4. Ichikawa T., and Umezawa H. Kasugamycin in Pseudomonas infections of the urinary tract. J Urol 97 (1967) 917-925
5. Takeuchi T., Ishizuka M., Takayama H., Kureha K., Hamada M., and Umezawa H. Pharmacology of kasugamycin and the effect on Pseudomonas infection. J Antibiot (Tokyo) 18 (1965) 107-110
6. Tamamura T., and Sato K. Comparative studies on in vitro activities of kasugamycin and clinically-used aminoglycoside antibiotics. Jpn J Antibiot 52 (1999) 57-67
7. Levitan A.A. In vitro antibacterial activity of kasugamycin. Appl Microbiol 15 (1967) 750-753
8. Schluenzen F., Takemoto C., Wilson D.N., Kaminishi T., Harms J.M., Hanawa-Suetsugu K., et al. The antibiotic kasugamycin mimics mRNA nucleotides to destabilize tRNA binding and inhibit canonical translation initiation. Nat Struct Mol Biol 13 (2006) 871-878
9. Schuwirth B.S., Day J.M., Hau C.W., Janssen G.R., Dahlberg A.E., Cate J.H., et al. Structural analysis of kasugamycin inhibition of translation. Nat Struct Mol Biol 13 (2006) 879-886
10. Dabbs E.R. Escherichia coli kasugamycin dependence arising from mutation at the rpsI locus. J Bacteriol 153 (1983) 709-715
11. Sparling P.F., Ikeya Y., and Elliot D. Two genetic loci for resistance to kasugamycin in Escherichia coli. J Bacteriol 113 (1973) 704-710
12. Vila-Sanjurjo A., Squires C.L., and Dahlberg A.E. Isolation of kasugamycin resistant mutants in the 16 S ribosomal RNA of Escherichia coli. J Mol Biol 293 (1999) 1-8
13. Zimmermann R.A., Ikeya Y., and Sparling P.F. Alteration of ribosomal protein S4 by mutation linked to kasugamycin-resistance in Escherichia coli. Proc Natl Acad Sci U S A 70 (1973) 71-75
14. Tominaga A., and Kobayashi Y. Kasugamycin-resistant mutants of Bacillus subtilis. J Bacteriol 135 (1978) 1149-1150
15. Andresson O.S., and Davies J.E. Some properties of the ribosomal RNA methyltransferase encoded by ksgA and the polarity of ksgA transcription. Mol Gen Genet 179 (1980) 217-222
16. Desai P.M., and Rife J.P. The adenosine dimethyltransferase KsgA recognizes a specific conformational state of the 30S ribosomal subunit. Arch Biochem Biophys 449 (2006) 57-63
17. Inoue K., Basu S., and Inouye M. Dissection of 16S rRNA methyltransferase (KsgA) function in Escherichia coli. J Bacteriol 189 (2007) 8510-8518
18. O'Farrell H.C., Scarsdale J.N., and Rife J.P. Crystal structure of KsgA, a universally conserved rRNA adenine dimethyltransferase in Escherichia coli. J Mol Biol 339 (2004) 337-353
19. Van Buul C.P., Damm J.B., and Van Knippenberg P.H. Kasugamycin resistant mutants of Bacillus stearothermophilus lacking the enzyme for the methylation of two adjacent adenosines in 16S ribosomal RNA. Mol Gen Genet 189 (1983) 475-478
20. Igarashi K., Kishida K., Kashiwagi K., Tatokoro I., Kakegawa T., and Hirose S. Relationship between methylation of adenine near the 3′ end of 16-S ribosomal RNA and the activity of 30-S ribosomal subunits. Eur J Biochem 113 (1981) 587-593
21. Poldermans B., and Goosen N. Van Knippenberg PH. Studies on the function of two adjacent N6,N6-dimethyladenosines near the 3′ end of 16 S ribosomal RNA of Escherichia coli. I. The effect of kasugamycin on initiation of protein synthesis. J Biol Chem 254 (1979) 9085-9089
22. Roa B.B., Connolly D.M., and Winkler M.E. Overlap between pdxA and ksgA in the complex pdxA-ksgA-apaG-apaH operon of Escherichia coli K-12. J Bacteriol 171 (1989) 4767-4777
23. Dabbs E.R., Poldermans B., Bakker H., and van Knippenberg P.H. Biochemical characterization of ribosomes of kasugamycin-dependent mutants of Escherichia coli. FEBS Lett 117 (1980) 164-166
24. U.S. Department of Health and Human Services C, Centers for Disease Control and Prevention (CDC). Sexually transmitted disease surveillance 2005 supplement: Gonococcal Isolate Surveillance Project (GISP) annual report 2005. CDC; January 2007.
25. Pariser H. Asymptomatic gonorrhea. Med Clin North Am 56 (1972) 1127-1132
26. Swasdio K., Rugpao S., Tansathit T., Uttavichai C., Jongusuk P., Vutayavanich T., et al. The association of Chlamydia trachomatis/gonococcal infection and tubal factor infertility. J Obstet Gynaecol Res 22 (1996) 331-340
27. O'Brien J.P., Goldenberg D.L., and Rice P.A. Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine 62 (1983) 395-406
28. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther 4 (2006) 619-628
29. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007;56:332-6.
30. Dillard J.P., and Seifert H.S. A variable genetic island specific for Neisseria gonorrhoeae is involved in providing DNA for natural transformation and is found more often in disseminated infection isolates. Mol Microbiol 41 (2001) 263-277
31. Seifert H.S., Wright C.J., Jerse A.E., Cohen M.S., and Cannon J.G. Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J Clin Invest 93 (1994) 2744-2749
32. Long C.D., Madraswala R.N., and Seifert H.S. Comparisons between colony phase variation of Neisseria gonorrhoeae FA1090 and pilus, pilin, and S-pilin expression. Infect Immun 66 (1998) 1918-1927
33. Kellogg Jr. D.S., Cohen I.R., Norins L.C., Schroeter A.L., and Reising G. Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J Bacteriol 96 (1968) 596-605
34. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M7-A4. Wayne, PA: NCCLS; 1997.
35. Andrews J.M. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48 Suppl. 1 (2001) 5-16 [Erratum in: J Antimicrob Chemother 2002,49:1049]
36. Serkin C.D., and Seifert H.S. Iron availability regulates DNA recombination in Neisseria gonorrhoeae. Mol Microbiol 37 (2000) 1075-1086
37. Stohl E.A., and Seifert H.S. The recX gene potentiates homologous recombination in Neisseria gonorrhoeae. Mol Microbiol 40 (2001) 1301-1310
38. Seifert H.S. Insertionally inactivated and inducible recA alleles for use in Neisseria. Gene 188 (1997) 215-220
39. Helm R.A., Barnhart M.M., and Seifert H.S. pilQ missense mutations have diverse effects on PilQ multimer formation, piliation, and pilus function in Neisseria gonorrhoeae. J Bacteriol 189 (2007) 3198-3207
40. Dabbs E.R. Kasugamycin-dependent mutants of Escherichia coli. J Bacteriol 136 (1978) 994-1001
41. Sparling P.F. Kasugamycin resistance: 30S ribosomal mutation with an unusual location on the Escherichia coli chromosome. Science 167 (1970) 56-58
42. Gibbs C.P., Reimann B.Y., Schultz E., Kaufmann A., Haas R., and Meyer T.F. Reassortment of pilin genes in Neisseria gonorrhoeae occurs by two distinct mechanisms. Nature 338 (1989) 651-652
43. Tessman E.S., Tessman I., Peterson P.K., and Forestal J.D. Roles of RecA protease and recombinase activities of Escherichia coli in spontaneous and UV-induced mutagenesis and in Weigle repair. J Bacteriol 168 (1986) 1159-1164
44. Galimand M., Gerbaud G., and Courvalin P. Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA. Antimicrob Agents Chemother 44 (2000) 1365-1366
45. O'Farrell H.C., Pulicherla N., Desai P.M., and Rife J.P. Recognition of a complex substrate by the KsgA/Dim1 family of enzymes has been conserved throughout evolution. RNA 12 (2006) 725-733
46. Lafontaine D., Vandenhaute J., and Tollervey D. The 18S rRNA dimethylase Dim1p is required for pre-ribosomal RNA processing in yeast. Genes Dev 9 (1995) 2470-2481
47. Lu Q., and Inouye M. The gene for 16S rRNA methyltransferase (ksgA) functions as a multicopy suppressor for a cold-sensitive mutant of Era, an essential RAS-like GTP-binding protein in Escherichia coli. J Bacteriol 180 (1998) 5243-5246
48. European Committee on Antimicrobial Susceptibility Testing. EUCAST clinical MIC breakpoints-aminoglycosides. 2008-06-19 (v 1.4).